🇺🇸 FDA

Intelligence · Clinical Pipeline

Metabolic & obesity · Approved programs

Metabolic & obesity programs at Approved programs — ClinicalTrials.gov pipeline intelligence.

Programs
105

Quick answer

Metabolic & obesity Approved programs programs: NovaPharmaNews indexes 105 matching clinical development programs from ClinicalTrials.gov with sponsor, modality, and NCT cross-links.

Top sponsors

Page 1 of 3

  1. AD-4833 15 mg

    Takeda

    Diabetes Mellitus

    approved small molecule completed

    1 trial

  2. Aflibercept

    Regeneron UK Limited

    Diabetic Macular Edema

    approved small molecule completed

    2 trials

  3. Aflibercept

    Regeneron UK Limited

    Diabetic Retinopathy

    approved small molecule completed

    2 trials

  4. Aflibercept (BAY86-5321, Eylea)

    Regeneron UK Limited

    Diabetic Macular Edema

    approved small molecule completed

    1 trial

  5. Aflibercept 8 mg (VEGF Trap-Eye, BAY86-5321)

    Regeneron UK Limited

    Diabetic Macular Edema (DME)

    approved small molecule active

    1 trial

  6. Aflibercept Injection

    Regeneron UK Limited

    Diabetic Retinopathy

    approved small molecule completed

    2 trials

  7. Alogliptin

    Takeda

    Diabetes Mellitus, Type 2

    approved small molecule completed

    6 trials

  8. Azilsartan

    Takeda

    Essential Hypertension Complicated by Type 2 Diabetes Mellitus

    approved small molecule completed

    1 trial

  9. Berberine

    The First People's Hospital of Lianyungang

    Diabetes Mellitus

    approved small molecule completed

    1 trial

  10. Berberine plus lifestyle intervention

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Obesity

    approved small molecule completed

    1 trial

  11. Blood Glucose Meter Systems

    Universal Integrated

    Diabetes

    approved other completed

    1 trial

  12. Breeze2 glucometer

    Hospital Authority, Hong Kong

    Diabetes

    approved other active

    1 trial

  13. COLECALCIFEROL , The Placebo product consists only of pure Ph. Eur. refined olive and it differs from Test product for the absence of active substance only: therefore, there are no reasons to suspect that the placebo product will undergo changes in its physical characteristics or degradation., Placebo

    Fondazione Telethon ETS

    obese elderly people with vitamin D deficiency

    approved small molecule active

    1 trial

  14. CSII

    The First People's Hospital of Lianyungang

    Diabetes Mellitus, Type 2

    approved small molecule completed

    1 trial

  15. Candesartan and Hydrochlorothiazide

    Takeda

    Obesity

    approved small molecule completed

    1 trial

  16. Capsules with microcrystalline cellulose, Colchicine Teva 0,5 mg, tabletten

    Disc Medicine

    Type 1 Diabetes

    approved small molecule active

    1 trial

  17. Commercial Hylenex® recombinant (hyaluronidase human injection)

    HALOZYME THERAPEUTICS, INC.

    Type 1 Diabetes Mellitus

    approved small molecule completed

    1 trial

  18. Dapagliflozin

    AstraZeneca

    Diabetes Mellitus, Type 2

    approved small molecule completed

    1 trial

  19. Dapagliflozin 10 MG

    The First People's Hospital of Lianyungang

    Type 2 Diabetes Mellitus

    approved small molecule active

    1 trial

  20. ESOMEPRAZOLE, ESOMEPRAZOLE

    Fondazione Telethon ETS

    obesity

    approved small molecule active

    1 trial

  21. EXPAREL

    Pacira Ireland Limited

    Obesity

    approved small molecule completed

    1 trial

  22. Exenatide

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Type 2 Diabetes Mellitus

    approved small molecule completed

    1 trial

  23. Exenatide

    The First People's Hospital of Lianyungang

    Type 2 Diabetes

    approved small molecule active

    1 trial

  24. Eylea 114.3 mg/ml solution for injection

    Bayer AG

    Neovascular age-related macular degeneration (nAMD), Diabetic macular edema (DME)

    approved small molecule active

    1 trial

  25. Fenofibrate 145 mg

    United Therapeutics Europe Ltd

    Diabetic Retinopathy

    approved small molecule completed

    1 trial

  26. Fespixon Cream

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Diabetic Foot Ulcer (DFU)

    approved small molecule terminated

    1 trial

  27. Finerenone

    Chinese University of Hong Kong

    Patients With Type 2 Diabetes

    approved small molecule active

    1 trial

  28. Glucagon-like peptide-1 receptor agonist：Semaglutide

    The First People's Hospital of Lianyungang

    Type 2 Diabetes

    approved small molecule active

    1 trial

  29. Henagliflozin Proline Tablets treatment

    The First People's Hospital of Lianyungang

    Diabetes Type 2

    approved small molecule active

    1 trial

  30. ILUVIEN

    ANI PHARMACEUTICALS INC

    Chronic Diabetic Macular Edema

    approved small molecule completed

    1 trial

  31. ILUVIEN 0.19 MG

    ANI PHARMACEUTICALS INC

    Diabetic Macular Edema (DME)

    approved small molecule completed

    1 trial

  32. INSULIN GLARGINE

    Sanofi-aventis Healthcare Pty Ltd

    Diabetes mellitus II

    approved small molecule active

    1 trial

  33. INSULIN GLARGINE (HOE901)

    Sanofi Pasteur

    Diabetes Mellitus, Type 2

    approved small molecule terminated

    1 trial

  34. IVC

    The First People's Hospital of Lianyungang

    Proliferative Diabetic Retinopathy

    approved small molecule active

    1 trial

  35. Iluvien 0.19 MG Drug Implant

    ANI PHARMACEUTICALS INC

    Diabetic Macular Edema

    approved small molecule active

    1 trial

  36. Insulin Glargine

    Sanofi Pasteur

    Diabetes Mellitus, Type 2

    approved small molecule completed

    2 trials

  37. Insulin Glargine

    Eli Lilly and Company

    Diabetes Mellitus, Type 2

    approved small molecule completed

    1 trial

  38. Insulin glulisine

    Sanofi Pasteur

    Diabetes Mellitus, Type 1

    approved small molecule completed

    1 trial

  39. Insulin lispro low mixture

    Eli Lilly and Company

    Type 2 Diabetes Mellitus

    approved small molecule completed

    1 trial

  40. Intravenous Ibuprofen

    CUMBERLAND PHARMACEUTICALS INC

    Obesity

    approved small molecule completed

    1 trial

  41. Intravitreal Aflibercept

    Regeneron UK Limited

    Diabetic Macular Edema

    approved small molecule terminated

    2 trials

  42. Invokana 100 mg film-coated tablets, Xigduo 5 mg/850 mg film-coated tablets, Vokanamet 150 mg/850 mg film-coated tablets, Forxiga 10 mg film-coated tablets, Vokanamet 50 mg/1,000 mg film-coated tablets, Invokana 300 mg film-coated tablets, Forxiga 5 mg film-coated tablets, Vokanamet 50 mg/850 mg film-coated tablets, Synjardy 12.5 mg/1,000 mg film-coated tablets, Synjardy 12.5 mg/850 mg film-coated tablets, Jardiance 25 mg film-coated tablets, Synjardy 5 mg/1,000 mg film-coated tablets, Xigduo 5 mg/1,000 mg

    Wuhan Createrna Science and Technology Co., Ltd

    Type 2 diabetes mellitus

    approved small molecule active

    1 trial

  43. Kerendia 20 mg film-coated tablets, Kerendia 10 mg film coated tablets, Jardiance 10 mg film-coated tablets

    Disc Medicine

    Albuminuria, Type 2 diabetes

    approved small molecule active

    1 trial

  44. Lantus 100 units/ml solution for injection in a cartridge, Lantus 100 units/ml solution for injection in a vial, Toujeo 300 units/ml DoubleStar, solution for injection in a pre-filled pen, Awiqli 700 units/mL solution for injection in pre-filled pen, Levemir FlexPen 100 units/ml solution for injection in pre-filled pen., Toujeo 300 units/ml DoubleStar, solution for injection in a pre-filled pen, Tresiba 200 units/mL FlexTouch solution for injection in pre-filled pen, Tresiba 100 units/mL FlexTouch solution

    NovoThirteen

    Type 2 diabetes

    approved small molecule active

    1 trial

  45. Liraglutide

    Sana Biotechnology

    Morbid Obesity

    approved small molecule completed

    1 trial

  46. Lixisenatide (AVE0010)

    Sanofi Pasteur

    Diabetes Mellitus, Type 2

    approved small molecule completed

    3 trials

  47. Maggot debridement therapy

    The First People's Hospital of Lianyungang

    Diabetic Foot Ulcers

    approved other active

    1 trial

  48. Metformin

    Takeda

    Type 2 Diabetes Mellitus

    approved small molecule completed

    1 trial

Frequently asked questions

How many metabolic & obesity Approved programs programs exist?

105 programs match both the therapeutic area and stage filters in our published index.

Data attribution: Data sources · All pipeline programs

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.